Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Integra Lifesciences Hldgs C (IART)

208 + Investors. Track Smart Money conviction in IART. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +7
Streak
1Q ▲
Buyers last Q
54%

Smart Money Signals — IART

Based on 208 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds added IART than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
📊

High ownership — 76% of 3.0Y peak

76% of all-time peak
208 funds currently hold this stock — 76% of the 3.0-year high of 272 funds (reached 2023 Q4). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
〰️

Stable — ownership unchanged year-over-year

fund count last 6Q
The number of hedge funds holding IART is almost the same as a year ago (+1 funds, +0% change). No significant rush to buy or sell — institutional backing is holding steady.
🟡

Slight buying edge — 54% buying

116 buying99 selling
Last quarter: 116 funds bought or added vs 99 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
📈

More new buyers each quarter (+14 vs last Q)

new funds entering per quarter
Funds opening a new IART position: 30 → 35 → 32 → 46. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔒

62% of holders stayed for 2+ years

■ 62% conviction (2yr+) ■ 19% medium ■ 19% new
130 out of 208 hedge funds have held IART for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💰

Price up while funds trimmed (+87% value, -2% shares)

Value
+86%
Shares
-1%
Last quarter: total value of institutional IART holdings rose +87% even though funds reduced share count by 2%. The stock price increased enough to offset the selling. Institutions are quietly trimming into price strength — watch for rotation.
📈

Growing discovery — still being found

37 → 30 → 35 → 32 → 46 new funds/Q
New funds entering each quarter: 30 → 35 → 32 → 46. A growing number of institutions are discovering IART each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
🏛️

Veteran-anchored — 67% veterans vs 23% newcomers

■ 67% veterans ■ 10% 1-2yr ■ 23% new
Entry-cohort mix of 208 holders: 140 (67%) are 2+ year veterans, 21 entered 1–2 years ago, and 47 (23%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 55% AUM from top-100 funds

55% from top-100 AUM funds
48 of 208 holders are among the 100 largest funds by AUM, controlling 55% of total institutional value in IART. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
2.3
out of 10
Low Exit Risk
Exit risk score 2.3/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — IART

In 2026 Q2, 116 hedge funds were net buyers of IART (46 opened a new position, 70 added to an existing one), while 99 reduced or exited (60 trimmed, 39 sold completely) — a 54% buyer ratio, indicating a slight buying edge. 55% of total institutional value in IART is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +7 funds (more new holders than closures). Total institutional holders: 208.

Hedge Fund Ownership: IART

How many hedge funds hold IART — quarterly history vs. share price
Quarterly hedge fund ownership of IART vs. share price

Market Analysis: IART

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: IART

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Integra Lifesciences Hldgs C (IART) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much IART has moved relative to its sector benchmark (XLV) since the 2026 Q2 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End June 30, 2026 · 60d ago
IART
-6.2%
XLV
+8.1%

IART outperformed XLV by -14.3% since June 30, 2026.

Since 13F Filing Date August 14, 2026 · 15d ago
IART
-8.1%
XLV
+2.5%

Since the filing became public, IART outperformed XLV by -10.6% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

11 top-rated funds 0 high-conviction
Consensus
4.7
/ 10
breadth
×
Elite
1.2
/ 10
conviction
Hedge Fund Positioning: IART
208 + Investors

Track Smart Money conviction in IART. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q2) Prior (2026 Q1) Change
Funds Holding 208 201 3.48%
13F Shares 73M 74M -1.82%
Total Value $1.30B $695M 86.73%
New Positions 46 32 +14
Increased Positions 70 63 +7
Closed Positions 39 36 +3
Reduced Positions 60 71 -11
Total Calls 0 0 -
Total Puts 0 0 -
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: IART

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

208 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in IART. Verified SEC 13F-HR filings.

QUARTER:
Top 25 IART holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Access Investment Management LLC 1.86% 405,002 $7.3M
2 Paradigm Capital Management Inc/Ny 1.68% 3,439,098 $61.8M
3 Rubric Capital Management LP 1.28% 7,753,934 $139.3M
4 Invenomic Capital Management LP 0.62% 579,036 $10.4M
5 PFM Health Sciences, LP 0.54% 348,746 $6.3M
6 SummerHaven Investment Management, LLC 0.51% 52,789 $948K
7 Integral Health Asset Management, LLC 0.39% 550,000 $9.9M
8 Systematic Financial Management LP 0.37% 1,023,243 $18.4M
9 Leeward Investments, LLC - MA 0.29% 350,152 $6.3M
10 Fuller & Thaler Asset Management, INC. 0.17% 3,436,006 $61.7M
11 VARCOV Co. 0.09% 12,509 $225K
12 Glenmede Trust Co NA 0.08% 948,142 $17.0M
13 WINTON GROUP Ltd 0.06% 102,632 $1.8M
14 New Age Alpha Advisors, LLC 0.06% 73,695 $1.3M
15 Mangrove Partners IM, LLC 0.05% 42,830 $769K
16 De Burlo Group Inc 0.05% 14,463 $260K
17 Mirabella Financial Services LLP 0.05% 27,319 $491K
18 Clearline Capital LP 0.05% 43,014 $773K
19 Susquehanna Portfolio Strategies, LLC 0.04% 152,371 $2.7M
20 State of Wyoming 0.04% 23,810 $428K
21 Headlands Technologies LLC 0.04% 21,462 $385K
22 Compass Financial Group, INC/SD 0.03% 14,043 $252K
23 Neuberger Berman Group LLC 0.03% 2,364,777 $42.6M
24 Mraz, Amerine & Associates, Inc. 0.03% 10,700 $192K
25 Inspire Investing, LLC 0.03% 37,239 $669K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Integra Lifesciences Hldgs C (IART)

What does the Smart Money Trend signal show for IART?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added IART than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for IART?

Slight buying edge — 54% buying: Last quarter: 116 funds bought or added vs 99 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for IART holders?

Elite ownership — 55% AUM from top-100 funds: 48 of 208 holders are among the 100 largest funds by AUM, controlling 55% of total institutional value in IART. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held IART?

62% of holders stayed for 2+ years: 130 out of 208 hedge funds have held IART for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Integra Lifesciences Hldgs C (IART) following the 2026 Q2 hedge fund 13F filings?

As of today, IART has moved -8.1% since the 2026 Q2 13F filing date (August 14, 2026), compared to +2.5% for the XLV sector ETF — an outperformance of -10.6%. Since the quarter end (June 30, 2026), IART has gained -6.2% vs +8.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →